Core Viewpoint - Shanghai Shanshi Capital will become an important strategic shareholder of MicroPort Medical [2][4] Group 1: Shareholder Changes - MicroPort Medical announced on July 25 that it has received notice from Otsuka Medical Devices Co., Ltd. regarding the conditional sale of approximately 291 million shares [2] - The buyers include funds under Shanghai Shanshi Capital, We'Tron Capital Limited, and the company's management investment platform [2] Group 2: Strategic Importance - The board of MicroPort Medical believes that Shanshi Capital will play a crucial role as a strategic shareholder, leveraging its state-owned background and industry resources to support the company's core business expansion and potential strategic acquisitions [4] - Shanshi Capital, established as an active fund management platform under Shanshi Group, focuses on investment opportunities in strategic emerging industries such as biomedicine and green environmental protection [4] Group 3: Financial Context - MicroPort Medical, founded in 1998 and headquartered in Zhangjiang, Shanghai, is a leading innovative high-end medical device group in China, but has reported continuous losses for five consecutive years [4] - On July 25, MicroPort Medical's stock closed at HKD 10.94 per share, with a 4.59% increase, and has surged 34% over the last three trading days, bringing its latest market capitalization to HKD 20.2 billion [6]
暴涨34%！上海国资，出手！